Sunday, March 17, 2013 8:08:13 AM
In essence, DocF's most recent post has a line that summarizes what Danman is about quite fittingly:
I don't see it that way at all. It wasn't the message, it was the method and style of delivery. It was also the refusal to acknowledge explanations and the constant spinning to be right.
Case in point, on toxicity: Dan wrote yesterday:
"now that they have gotten past the first cohort without significant toxicity"
Several days ago he said:
"This suggests that this growth suppressive, pro-apoptotic (cell death) pathway is activated in normal cells.To me, this would suggest significant toxicity, because it would inhibit the growth of the normal cells that are supposed to be growing, which is similar to what happens with normal chemotherapies."
So far he has refused to directly commented on this polar opposite change of stand.
Then, yesterday while talking with DocF, Danman brought up a nutlin study, to support his view on kevetrin. Although both agents are associated with P53, Danman knows full well they have vastly different MOA. Yet, he went on to argue that, despite his insistence that he does not know Kevetrin's MOA, that Kevetrin and nutlin are comparable. This is what DocF is talking about: spinning.
To me it is shocking and dispicable to see a student of science blatantly uses science for his personal gain.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • Oct 10, 2024 8:09 AM
FEATURED CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM